deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT01545037

Effect of BIO-K+ on Symptoms of Irritable Bowel Syndrome

Effect of Lactobacillus Acidophilus CL1285®, L. Casei LBC80R® and L. Rhamnosus CLR2® on Symptoms of Irritable Bowel Syndrome: a Double-blind, Randomized, Placebo-controlled Study

Sponsor: Bio-K Plus International Inc.

Conditions Irritable Bowel Syndrome
Interventions L. acidophilus CL1285® + L. casei LBC80R® + L. rhamnosus CLR2® Placebo
Updated 7 times since 2017 Last updated: Jul 27, 2017 Started: Jul 31, 2012 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Irritable Bowel Syndrome, this trial is completed. The trial is conducted by Bio-K Plus International Inc. and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Sep 2017 · 7 months · monthly snapshotCompleted~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

  5. Sep 2017 — Jun 2018 [monthly]

    Completed PHASE2

    Phase: PHASE2_PHASE3 → PHASE2

▶ Show 2 earlier versions

  1. Feb 2017 — Sep 2017 [monthly]

    Completed PHASE2_PHASE3

  2. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE2_PHASE3

    First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bio-K Plus International Inc.
  • Sprim Advanced Life Sciences
Data source: Bio-K Plus International Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations